Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 'Mentalizing' therapy tame teen conduct disorders?

NCT ID NCT07181928

Disease control Sponsor: University Hospital Heidelberg Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compares two treatments for teens aged 12-19 with oppositional defiant or conduct disorders. One group gets mentalization-based therapy (MBT), which helps teens understand their own and others' thoughts and feelings. The other group gets standard psychiatric care plus emotion-focused parent training. The goal is to see which approach leads to more teens no longer meeting the diagnosis for their disorder.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mentalization-Based Therapy (MBT) and Treatment-as-usual-plus (TAU-plus) (emotion-focused parent training with supportive child psychiatric care)
What this could lead to
If MBT works better, it could offer a more effective therapy option for teens with disruptive behavior disorders, reducing symptoms and improving family relationships.
What could go wrong
This is a relatively small trial (90 participants) that hasn't started yet. The therapy is behavioral, so results may vary, and it may not work for everyone. There is no drug or cure involved.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 19 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Primary diagnosis of Oppositional defiant disorder (ODD) / Conduct-dissocial disorder (CDD) (ICD-11: 6C90-6C91; ICD-10: F91.0-F91.9; DSM-5: 312.81, 313.81) * Aged 12 to 19 years * Living with their parents * Provide written informed consent (plus parental consent for minors) * At least one parent provides written informed consent and agrees to active participation in treatment and study, including randomization Exclusion Criteria: * Severe acute substance dependence requiring inpatient detoxification * Acute psychotic symptoms or early-onset schizophrenia * Neurological impairments or intellectual disability (IQ \< 80) * Insufficient proficiency in German * Other clinical contraindications for outpatient psychotherapy (e.g., acute suicidality)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Conduct disorders in adolescence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

antisocial personality disorder conduct disorder oppositional defiant disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Conduct disorders in adolescence Oppositional defiant disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institut für Psychosoziale Prävention, Ruprecht-Karls-Universität Heidelberg

    Heidelberg, Baden-Wurttemberg, 69115, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.